Style | Citing Format |
---|---|
MLA | Safari S, et al.. "Synthesis, Biological Evaluation and Molecular Docking Study of Dihydropyrimidine Derivatives As Potential Anticancer Agents." Journal of Heterocyclic Chemistry, vol. 57, no. 3, 2020, pp. 1023-1033. |
APA | Safari S, Ghavimi R, Razzaghiasl N, Sepehri S (2020). Synthesis, Biological Evaluation and Molecular Docking Study of Dihydropyrimidine Derivatives As Potential Anticancer Agents. Journal of Heterocyclic Chemistry, 57(3), 1023-1033. |
Chicago | Safari S, Ghavimi R, Razzaghiasl N, Sepehri S. "Synthesis, Biological Evaluation and Molecular Docking Study of Dihydropyrimidine Derivatives As Potential Anticancer Agents." Journal of Heterocyclic Chemistry 57, no. 3 (2020): 1023-1033. |
Harvard | Safari S et al. (2020) 'Synthesis, Biological Evaluation and Molecular Docking Study of Dihydropyrimidine Derivatives As Potential Anticancer Agents', Journal of Heterocyclic Chemistry, 57(3), pp. 1023-1033. |
Vancouver | Safari S, Ghavimi R, Razzaghiasl N, Sepehri S. Synthesis, Biological Evaluation and Molecular Docking Study of Dihydropyrimidine Derivatives As Potential Anticancer Agents. Journal of Heterocyclic Chemistry. 2020;57(3):1023-1033. |
BibTex | @article{ author = {Safari S and Ghavimi R and Razzaghiasl N and Sepehri S}, title = {Synthesis, Biological Evaluation and Molecular Docking Study of Dihydropyrimidine Derivatives As Potential Anticancer Agents}, journal = {Journal of Heterocyclic Chemistry}, volume = {57}, number = {3}, pages = {1023-1033}, year = {2020} } |
RIS | TY - JOUR AU - Safari S AU - Ghavimi R AU - Razzaghiasl N AU - Sepehri S TI - Synthesis, Biological Evaluation and Molecular Docking Study of Dihydropyrimidine Derivatives As Potential Anticancer Agents JO - Journal of Heterocyclic Chemistry VL - 57 IS - 3 SP - 1023 EP - 1033 PY - 2020 ER - |